Federal health officials are reviewing the safety of two injectable drugs used to protect babies and toddlers from the RSV virus. The drugs from Merck and Sanofi are not vaccines. But officials under Health Secretary Robert F. Kennedy Jr. have recently been scrutinizing a number of childhood shots.
KOB 4's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Names this update
FDA opens safety review of injectable RSV drugs approved for babies and toddlers
Headline from KOB 4 ·
Newest
US FDA launches fresh safety scrutiny of approved RSV therapies for infants
The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations to face scrutiny under Health Secretary RFK, Jr.
FDA officials are newly scrutinizing several approved therapies to treat RSV in babies despite the fact that these shots were shown to be safe in clinical trials
Federal health officials are reviewing the safety of two injectable drugs used to protect babies and toddlers from the RSV virus. The drugs from Merck and Sanofi are not vaccines. But officials under Health Secretary Robert F. Kennedy Jr. have recently been scrutinizing a number of childhood shots.
U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following concerns raised by vaccine skeptics, multiple sources familiar with the situation told Reuters.
